CalciMedica, Inc. , a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies.
Calcimedica stock last closed at $1.60, down 3.03% from the previous day, and has decreased 89.51% in one year. It has underperformed other stocks in the Biotechnology industry by 0.15 percentage points. Calcimedica stock is currently +1.27% from its 52-week low of $1.58, and -95.56% from its 52-week high of $36.00.
As of Oct 2, 2026, there are 6.83M shares of CALC outstanding. The market cap of CALC is $10.93M. In the last 24 hours, 21,700 CALC shares were traded.
You need a brokerage account to access the NASDAQ market and buy CALC stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal info so you are able to buy CALC stock today.
Now that you have opened your account on stock market apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your new brokerage account.
Once you have decided on the best place to buy Calcimedica stock, it's very important to analyze their stock before you buy, so you actually wrap your head around the risk and opportunity.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on CALC's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CALC's true value.
Using relative valuations ratios:
You can do additional valuation research on CALC's stock here.
Out of 1 Equities analysts who monitor CALC, the consensus analyst rating on Calcimedica is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Calcimedica stock forecast page.
Over the past 12 months, insiders at CALC have bought more shares than they have sold.
Sudarshan Hebbar, Chief Medical Officer of CALC, was the latest CALC insider to buy. They bought $99,962.26 worth of CALC shares on Jun 25, 2026.
Get more info about who owns CALC stock here.
No, Calcimedica doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary types of orders:
Hit the Open button and eToro will execute your order.
If you want more help investing in stocks on eToro, click the how to video below:
Now that you own some CALC stock, you'll want to stay up-to-date on your company.
Start a watchlist to see the latest developments about your CALC stock.
To reiterate, here are the 6 steps you need to take to buy Calcimedica stock right now:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Calcimedica, create a watchlist on WallStreetZen today.